FolioLanternBeta
JAZZJazz Pharmaceuticals plc

Bruce Cozadd

Director at Jazz Pharmaceuticals plc, as of Oct 5, 2026Sold $27.8M of stock in the past 12 months: 39% under a disclosed plan and 61% with no plan disclosed.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
346K
shares held after the latest filing, Jazz Pharmaceuticals plc
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
144K
shares sold, past 12 months
10
days with sales
$13.8M
largest single day, Nov 26, 2025
1
company filed for

Share of stake sold at Jazz Pharmaceuticals plc is not shown: most of their shares vested during the period, so a percentage would mislead. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNov 2025: $17.0M no plan disclosed$17.0MNovDecJanFebMar 2026: $1.1M under a disclosed planMarApr 2026: $1.1M under a disclosed planAprMay 2026: $1.2M under a disclosed planMayJun 2026: $1.4M under a disclosed planJunJul 2026: $1.4M under a disclosed planJulAug 2026: $1.5M under a disclosed planAugSep 2026: $1.5M under a disclosed planSepOct 2026: $1.4M under a disclosed planOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Jazz Pharmaceuticals plc (JAZZ)DirectorMay 31, 2007Oct 5, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.